Increased tumor necrosis factor-receptor superfamily plasma levels are associated with early renal or retinal involvement in intermediate hyperglycemia

Our findings highlight the potential of TNF receptor superfamily members as biomarkers for early-stage renal and retinal complications in individuals with IH. Their integration into clinical screening protocols could facilitate earlier detection, improving patient stratification and personalized management strategies. Further longitudinal studies are necessary to validate their predictive value and potential for guiding therapeutic interventions in IH and early diabetes management.

Authors

Institutions

Publication Details

Journal
World Journal of Diabetes
Published
2025-09-10
DOI
https://doi.org/10.4239/wjd.v16.i9.106002
Primary Topic
Diabetes and associated disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Increased tumor necrosis factor-receptor superfamily plasma levels are associated with early renal or retinal involvement in intermediate hyperglycemia

Esther Civantos, Carmen Gómez‐Guerrero, Marcus Lind, Juan Antonio Moreno et al.
World Journal of Diabetes
Diabetes and associated disorders
article

Increased tumor necrosis factor-receptor superfamily plasma levels are associated with early renal or retinal involvement in intermediate hyperglycemia

Esther Civantos, Carmen Gómez‐Guerrero, Marcus Lind, Juan Antonio Moreno, María Isabel López Gálvez, Sebastián Mas, Jaakko Tuomilehto, Nisa Boukichou-Abdelkader, Rafael Gabriel, Jesús Egido
article en

Abstract

Our findings highlight the potential of TNF receptor superfamily members as biomarkers for early-stage renal and retinal complications in individuals with IH. Their integration into clinical screening protocols could facilitate earlier detection, improving patient stratification and personalized management strategies. Further longitudinal studies are necessary to validate their predictive value and potential for guiding therapeutic interventions in IH and early diabetes management.

World Journal of DiabetesVol. 16(9)
Universidad de Valladolid (ES), University of Helsinki (FI), Universidad de La Rioja (ES), Instituto de Salud Carlos III (ES), Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES), Finland University (FI), 358 (Finland) (FI), Hospital Universitario Fundación Jiménez Díaz (ES), Universidad Alfonso X el Sabio (ES), University of Córdoba (ES), Universidad Autónoma de Madrid (ES), University of Gothenburg (SE)
Openalex Percentile: Top 74%
Diabetes and associated disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.